Table 1 Summary of clinical, genetic, and biochemical studies

From: Vascular Ehlers–Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family

Family member

COL3A1 genotype

Dermal fibroblasts

Clinical major features

Clinical minor features

Additional clinical features

III-1

No variant found

Not done

None

None

 

III-2 Proband

c.1786C>T, p.(Arg596*) and c.3851G>A, p.(Gly1284Glu)

Not done, sample not available

Arterial dissections, fatal at age 15. Thin, translucent skin. Characteristic facial appearance

Talipes equinovarus

Hydrocele of testis. Long, slender fingers

III-3

c.1786C>T, p.(Arg596*) and c.3851G>A, p.(Gly1284Glu)

Abnormal type III collagen, reduced amount

Arterial dissections. Characteristic facial appearance. Thin, translucent skin. Easy bruising

First-degree relative with vascular EDS. Small joint hypermobility. Tendon rupture

Cerebrocortical anomalies. Long, slender fingers

II-3

c.1786C>T p.(Arg596*)

Not done

None

Early-onset varicose veins

 

II-4

c.1786C>T p.(Arg596*)

Not done

None

None

Umbilical and inguinal hernia

II-5

c.1786C>T p.(Arg596*)

Reduced amount type III collagen

None

First-degree relative with vascular EDS

 

II-6

c.3851G>A p.(Gly1284Glu)

Abnormal type III collagen

Thin, translucent skin

First-degree relative with vascular EDS. Small joint hypermobility

Bilateral pulmonary emphysema. Reduced ascending aorta elastisity

II-7

No variant found

Not done

None

None

 

I-2

c.1786C>T p.(Arg596*)

Not done

None

None

 

I-3

Not available

Not done, sample not available

Cerebral hemorrhage, fatal at age 43

Not examined

 
  1. Clinical major and minor features are listed according to the current Villefranche criteria.7